Objectives
• Explain the differences among light, moderate, and deep levels of sedation.
• Describe the role of standardized assessment tools to determine sedation requirements.
• Compare and contrast the pharmacological agents used to provide sedation.
• List the risk factors for development of delirium in critical illness.
• Describe the management of delirium tremens in critical illness.
Be sure to check out the bonus material, including free self-assessment exercises, on the Evolve web site at http://evolve.elsevier.com/Urden/priorities/.
One of the challenges facing clinicians is how to provide a therapeutic healing environment for patients in the alarm-filled, emergency-focused critical care unit. Many critical care patients demonstrate some degree of agitation and discomfort caused by painful procedures, invasive tubes, sleep deprivation, fear, anxiety, and physiological stress.
Clinical practice guidelines were developed by the Society of Critical Care Medicine (SCCM) to increase awareness of these issues in the critically ill.1 The goal is to find a balance between providing compassionate patient care and avoiding the perils of oversedation.
Sedation
Sedation Scales
The use of scoring systems to assess and record levels of sedation and agitation is now strongly recommended.1 Four frequently used scales are the Ramsay Scale,2 the Riker Sedation-Agitation Scale (SAS),3 the Motor Activity Assessment Scale (MAAS),4 and the Richmond Agitation-Sedation Scale (RASS)5,6 (Table 9-1). Because individuals do not metabolize sedative medications at the same rate, the use of a standardized scale can ensure that continuous infusions of sedatives such as propofol or lorazepam are titrated to a specific goal. Collaboratively, the critical care team must determine which level of sedation is most appropriate for each individual patient.1
TABLE 9-1
SCORE | DESCRIPTION | DEFINITION | |
Riker Sedation-Agitation Scale (SAS)* | |||
7 | Dangerously agitated | Pulls at endotracheal tube (ETT), tries to remove catheters, climbs over bed rail, strikes at staff, thrashes side to side | |
6 | Very agitated | Does not calm despite frequent verbal reminding of limits, requires physical restraints, bites ETT | |
5 | Agitated | Anxious or mildly agitated, attempts to sit up, calms down to verbal instructions | |
4 | Calm and cooperative | Calm, awakens easily, follows commands | |
3 | Sedated | Difficult to arouse, awakens to verbal stimuli or gentle shaking but drifts off again; follows simple commands | |
2 | Very sedated | Arouses to physical stimuli but does not communicate or follow commands; may move spontaneously | |
1 | Unarousable | Minimal or no response to noxious stimuli; does not communicate or follow commands | |
Motor Activity Assessment Scale (MAAS)† | |||
6 | Dangerously agitated | No external stimulus required to elicit movement; is uncooperative, pulls at tubes or catheters, thrashes side to side, strikes at staff, tries to climb out of bed, does not calm down when asked | |
5 | Agitated | No external stimulus required to elicit movement; attempts to sit up or move limbs out of bed, does not consistently follow commands (e.g., will lie down when asked but soon reverts back to attempts) | |
4 | Restless and cooperative | No external stimulus required to elicit movement; picks at sheets or tubes or uncovers self; follows commands | |
3 | Calm and cooperative | No external stimulus required to elicit movement; adjusts sheets or clothes purposefully; follows commands | |
2 | Responsive to touch or name | Opens eyes, raises eyebrows, or turns head toward stimulus; or, moves limbs when touched or when name loudly spoken | |
1 | Responsive only to noxious stimulus | Opens eyes, raises eyebrows, or turns head toward stimulus; or, moves limbs with noxious stimulus | |
0 | Unresponsive | Does not move with noxious stimulus | |
Ramsey Scale‡ | |||
1 | Awake | Anxious; agitated and/or restless | |
2 | Cooperative, oriented, and tranquil | ||
3 | Responds only to commands | ||
4 | Asleep | Brisk response to light glabellar tap or loud auditory stimulus | |
5 | Sluggish response to light glabellar tap or loud auditory stimulus | ||
6 | No response to light glabellar tap or loud auditory stimulus | ||
Richmond Agitation-Sedation Scale (RASS)§,¶ | |||
+4 | Combative | Overtly combative, violent, immediate danger to staff | |
+3 | Very agitated | Pulls or removes tube(s) or catheter(s); aggressive | |
+2 | Agitated | Frequent nonpurposeful movement, fights ventilator | |
+1 | Restless | Anxious but movements not aggressive or vigorous | |
0 | Alert and calm | ||
−1 | Drowsy | Not fully alert, but has sustained awakening (eye-opening/eye contact) to voice (≥10 seconds) | } Verbal Stimulation |
−2 | Light sedation | Briefly awakens with eye contact to voice (<10 seconds) | |
−3 | Moderate sedation | Movement or eye opening to voice (but no eye contact) | |
−4 | Deep sedation | No response to voice, but movement or eye opening to physical stimulation | } Physical Stimulation |
−5 | Unresponsive | No response to voice or physical stimulation |
*Riker RR, et al: Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients, Crit Care Med 27(7):1325, 1999.
†Devlin JW, et al: Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit, Crit Care Med 27(7):1271, 1999.
‡Ramsay MA, et al: Controlled sedation with alphaxalone-alphadolone, Br Med J 2(5920):656, 1974.
§Sessler CN, et al: The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients, Am J Respir Crit Care Med 166(10):1338, 2002.
¶Ely EW, et al: Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS), JAMA 289(22):2983-2991, 2003.
The first step in assessing the agitated patient is to rule out any sensations of pain.1 Clinical assessment is more challenging when the patient is obtunded or has an artificial airway in place. If the patient can communicate, the verbal pain scale of 0 to 10 is very useful. If the patient is intubated and cannot vocalize, pain assessment becomes considerably more complex. After medication for pain has been provided, the next step is to determine the minimum level of sedation required (Box 9-1). The SCCM guidelines recommend that all critically ill, intubated, mechanically ventilated patients have stated goals for analgesia and sedation1 (Figure 9-1). The use of validated assessment scales is advised (see Table 9-1).
Complications of Sedation
Oversedation is recognized as a state of unintended patient unresponsiveness in which the patient resides in a state of suspended animation resembling general anesthesia. Prolonged deep sedation is associated with significant complications of immobility, including pressure ulcers, thromboemboli, gastric ileus, nosocomial pneumonia, and delayed weaning from mechanical ventilation.
Too little sedation is equally hazardous. Most nurses have experienced the challenge of caring for a patient who unexpectedly removes the endotracheal or nasogastric tube. Unplanned extubation in restless, anxious, agitated patients occurs in 8% to 10% of intubated patients after an average of 3.5 days in the critical care unit. Six percent of self-extubation events cause significant complications, including aspiration, dysrhythmias, bronchospasm, and bradycardia.7
Pharmacological Management of Sedation
Several categories of sedatives are available. If the patient is experiencing pain, analgesia must be administered in addition to any sedative agents. Sedative agents include the benzodiazepines, sedative-hypnotic agents such as propofol, and the central alpha agonists (Table 9-2).1
TABLE 9-2
PHARMACOLOGICAL MANAGEMENt: Sedation
DRUGS | DOSAGE | ACTIONS | SPECIAL CONSIDERATIONS |
Benzodiazepines | |||
Diazepam | 0.03-0.1 mg/kg every 0.5-6 hr (slow IV intermittent doses) | ||
Lorazepam | 0.02-0.06 mg/kg every 2-6 hr (slow IV intermittent doses) | ||
0.01-0.1 mg/kg/hr (continuous infusion) | |||
Midazolam | 0.02-0.08 mg/kg every 0.5-2 hr (slow IV intermittent doses) | ||
0.04-0.2 mg/kg/hr (continuous infusion) | |||
Sedative-Hypnotics | |||
Propofol | 5-80 mcg/kg/min (continuous infusion) | ||
Neuroleptic Agents | |||
Haloperidol | 0.03-0.15 mg/kg every 0.5-6 hr (IV intermittent doses) | ||
0.04-0.15 mg/kg/hr (continuous infusion) |